The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A three-dimensional human neural cell culture model of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beading or blebbing in neurites is a marker of dystrophic neurites in the AD brain (3, 42, 43).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, tau protein becomes hyperphosphorylated, resulting in tau dissociating from microtubules and forming insoluble tau aggregates in the neurites and cell bodies (3, 37).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Choi et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modeling these pathological hallmarks has largely relied on transgenic cellular and animal models harboring genetic mutations linked to ADAD (3–5).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“As for human neurons, previous studies focused on overexpressing mutant APP and Presenilin in REN stem cells grown in a 3D culture (3), which differs from patient-specific LOAD model that relies on the endogenous recapitulation of AD-associated phenotypes as provided in this study.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
In the citing paper
“one study revealed that familial AD (FAD) mutations in β-amyloid precursor protein and presenilin 1 induced robust extracellular deposition of amyloid-β in a human neural stem-cell-derived 3D culture system85.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“the 3D-differentiated neuronal cells expressing FAD mutations exhibited aggregates of phosphorylated tau as well as filamentous tau.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“A 3D in vitro culture system consisting of human neurons differentiated from induced pluripotent stem cells overexpressing human APP containing FAD mutations generates robust Aβ42 production and amyloid deposition. Importantly, this model also develops elevated phospho-tau levels and fibrillary tau aggregates, suggesting that elevated Aβ levels alone are sufficient to drive tau pathology in human”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Choi et al., 2014
In the citing paper
“It was recently shown that development of a 3D culture of human neural stem cells transfected with APPK670N/M671L/V717I and PS1ΔE9 in Matrigel scaffolding resulted in the extracellular aggregation of Aβ into plaques and the intracellular aggregation of tau in dystrophic neurites and the cell soma [23, 77].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Cohen, R. M., Rezai-Zadeh, K. P., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I. E., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 555
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Flagged first, then by citations
Research works printed but not linked: 1
- Higuchi, M., Trojanowski, J. Q. & Lee, V. M.-Y. Tau protein and tauopathy. Neuropsychopharmacology: The Fifth Generation of Progress (eds Davis, K. L., Charney, D., Coyle, J. T. & Nemeroff, C. ) 1339–1354 (Lippincott, Williams & Wilkins, 2002)
Cited by
Sorted by citations
Items 301–400 of 998
Kundu, A., McCoy, L., Azim, N., Nguyen, H. T., Didier, C. M., Ausaf, T., Sharma, A. D., Curley, J. L., Moore, M. J., & Rajaraman, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01184 · Cited by 53
Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606
Wagner, S. L., Rynearson, K. D., Duddy, S. K., Zhang, C. M., Nguyen, P. D., Becker, A., Vo, U., Masliah, D., Monte, L., Klee, J. B., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240861 · Cited by 49
Self-citationKlotho inhibits neuronal senescence in human brain organoids
Shaker, M. R., Aguado, J., Chaggar, H. K., & Wolvetang, E. J. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00070-x · Cited by 52
Shimada, H., Sato, Y., Sasaki, T., Shimozawa, A., Imaizumi, K., Shindo, T., Miyao, S., Kiyama, K., Kondo, T., Shibata, S., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100289 · Cited by 50
Cellular reprogramming as a tool to model human aging in a dish
Pitrez, P. R., Monteiro, L. M., Borgogno, O., Nissan, X., Mertens, J., & Ferreira, L. (2024) · Nature Communications · doi:10.1038/s41467-024-46004-5 · Cited by 51
Biomimetic on-a-chip platforms for studying cancer metastasis
Lee, E., Song, H.-H. G., & Chen, C. S. (2015) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2015.12.001 · Cited by 49
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 48
Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery
Zhao, H., & Yan, F. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10661-8 · Cited by 52
Cornaglia, M., Krishnamani, G. H., Mouchiroud, L., Sorrentino, V., Lehnert, T., Auwerx, J. H., & Gijs, M. A. M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0083-6 · Cited by 52
Chalard, A. E., Vaysse, L., Joseph, P., Malaquin, L., Assié-Souleille, S., Lonetti, B., Sol, J., Loubinoux, I., & Fitremann, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b01365 · Cited by 48
Chen, Q., Ma, H., Guo, X., Liu, J., Gui, T., & Gai, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.920065 · Cited by 48
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
Lu, Q., & Julia, T. C. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031203 · Cited by 49
Jovanovic, K., Chetty, C. J., Khumalo, T., Dias, B. D. C., Ferreira, E., Malindisa, S. T., Caveney, R. J., Letsolo, B. T., & Weiss, S. F. T. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1014802 · Cited by 48
Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
Morshed, N., Ralvenius, W. T., Nott, A., Watson, L. A., Rodriguez, F. H., Akay, L. A., Joughin, B. A., Pao, P., Penney, J., LaRocque, L. M., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209819 · Cited by 48
Organoids: A new approach in toxicity testing of nanotherapeutics
Nabi, S. U., Ali, S. I., Rather, M. A., Sheikh, W. M., Altaf, M., Singh, H., Mumtaz, P. T., Mishra, N. C., Nazir, S. U., & Bashir, S. M. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4206 · Cited by 47
Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction
Pavlou, G., Spitz, S., Pramotton, F. M., Tsai, A., Li, B. M., Wang, X., Barr, O. M., Ko, E. C., Zhang, S., Ashley, S. J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122864 · Cited by 50
Self-citationEngineered 3D immuno-glial-neurovascular human miBrain model
Stanton, A. E., Bubnys, A., Agbas, E., James, B. T., Park, D. S., Jiang, A. Y. L., Pinals, R. L., Liu, L., Truong, N., Loon, A. R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2511596122 · Cited by 51
Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease
Kwak, K.-A., Lee, S., Yang, J.-Y., & Park, Y. (2018) · Stem Cells International · doi:10.1155/2018/6392986 · Cited by 50
Self-citationFunctional and Sustainable 3D Human Neural Network Models from Pluripotent Stem Cells
Cantley, W. L., Du, C., Lomoio, S., DePalma, T. J., Peirent, E. R., Kleinknecht, D., Hunter, M., Tang‐Schomer, M. D., Tesco, G., & Kaplan, D. L. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00622 · Cited by 48
Layer-By-Layer: The Case for 3D Bioprinting Neurons to Create Patient-Specific Epilepsy Models
Antill‐O'Brien, N., Bourke, J., & O’Connell, C. D. (2019) · Materials · doi:10.3390/ma12193218 · Cited by 49
Emerging technologies to study glial cells
Hirbec, H., Déglon, N., Foo, L. C., Goshen, I., Grutzendler, J., Hangen, E., Kreisel, T., Linck, N., Muffat, J., Regio, S., et al. (2020) · Glia · doi:10.1002/glia.23780 · Cited by 51
Self-citationHernández-Sapiéns, M. A., Reza-Zaldívar, E. E., Cevallos, R. R., Márquez-Aguirre, A. L., Gazarian, K. G., & Canales-Aguirre, A. A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00151 · Cited by 46
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research
Bi, F.-C., Yang, X.-H., Cheng, X.-Y., Deng, W.-B., Guo, X.-L., Yang, H., Wang, Y., Li, J., & Yao, Y. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00252-3 · Cited by 49
Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations
Yao, J., Wu, X., Zhang, D., Wang, L., Zhang, L., Reynolds, E. X., Hernandez, C., Boström, K. I., & Yao, Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125965 · Cited by 44
Modelling neurodegenerative disease using brain organoids
Wray, S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.05.012 · Cited by 45
Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)
Wang, Y.-J., Monteagudo, A., Downey, M. A., Ashton‐Rickardt, P. G., & Elmaleh, D. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-85702-8 · Cited by 47
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms
Sreenivasamurthy, S., Laul, M., Zhao, N., Kim, T., & Zhu, D. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10378 · Cited by 49
Langerscheidt, F., Wied, T., Kabbani, M. A. A., van Eimeren, T., Wunderlich, G., & Zempel, H. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12314-3 · Cited by 52
Yan, Y., Bejoy, J., Xia, J., Guan, J., Zhou, Y., & Li, Y. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.027 · Cited by 45
The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43
Sandström, J., Eggermann, E., Charvet, I., Roux, A., Toni, N., Greggio, C., Broyer, A., Monnet-Tschudi, F., & Stoppini, L. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.10.001 · Cited by 44
Zhang, Y., Chen, H., Long, X., & Xu, T. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.023 · Cited by 44
Self-citationChallenges, solutions, and recommendations for Alzheimer's disease combination therapy
Hendrix, J. A., Bateman, R. J., Brashear, H. R., Duggan, C. D., Carrillo, M. C., Bain, L. J., Demattos, R. B., Katz, R. G., Ostrowitzki, S., Siemers, E., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.007 · Cited by 44
Lin, H., Li, Q., & Lei, Y. (2017) · Biofabrication · doi:10.1088/1758-5090/aa663b · Cited by 44
Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
Lauschke, K., Frederiksen, L., & Hall, V. J. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0003 · Cited by 46
Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome
Zhang, C. M., Ward, J. F., Dauch, J. R., Tanzi, R. E., & Cheng, H. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192333 · Cited by 44
Self-citation3D biomaterial models of human brain disease
Kajtez, J., Nilsson, F., Fiorenzano, A., Parmar, M., & Emnéus, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105043 · Cited by 45
Impact of the Flavonoid Quercetin on β-Amyloid Aggregation Revealed by Intrinsic Fluorescence
Alghamdi, A., Birch, D. J. S., Vyshemirsky, V., & Rolinski, O. J. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c02763 · Cited by 43
Alzheimer's disease and other dementias: advances in 2014
Bateman, R. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70301-1 · Cited by 43
Castrillo, J. I., Lista, S., Hampel, H. J., & Ritchie, C. W. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_3 · Cited by 44
Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model
Taylor-Whiteley, T. R., Maitre, C. L. L., Duce, J. A., Dalton, C., & Smith, D. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038042 · Cited by 43
Chiang, M., Nicol, C. J. B., Lin, C., Chen, S., Yen, C., & Huang, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104992 · Cited by 44
Exploring the neurogenic differentiation of human dental pulp stem cells
Al‐Maswary, A. A., O’Reilly, M., Holmes, A. P., Walmsley, A. D., Cooper, P. R., & Scheven, B. A. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277134 · Cited by 43
Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change
McMillan, P. J., Benbow, S. J., Uhrich, R. L., Saxton, A. D., Baum, M., Strovas, T. J., Wheeler, J. M., Baker, J. D., Liachko, N. F., Keene, C. D., et al. (2023) · Brain · doi:10.1093/brain/awad032 · Cited by 43
McMillan, I. O., Li, J., & Wang, L. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00247.2022 · Cited by 49
Timmers, M., Tesseur, I. C., Bogert, J., Zetterberg, H., Blennow, K., Börjesson‐Hanson, A., Baquero, M., Boada, M., RANDOLPH, C. C., Tritsmans, L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.016 · Cited by 43
iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery
Costamagna, G., Andreoli, L., Corti, S. P., & Faravelli, I. (2019) · Cells · doi:10.3390/cells8111438 · Cited by 40
Raman, S., Brookhouser, N., & Brafman, D. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104788 · Cited by 41
Wasielewska, J. M., Chaves, J. C. S., Johnston, R. L., Milton, L. A., Hernández, D., Chen, L., Song, J. H., Lee, W., Leinenga, G., Nisbet, R. M., et al. (2022) · Theranostics · doi:10.7150/thno.72685 · Cited by 41
Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
Castrillo, J. I., & Oliver, S. G. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2627-5_1 · Cited by 44
Brain organoids: A promising model to assess oxidative stress‐induced central nervous system damage
Oyefeso, F. A., Muotri, A. R., Wilson, C. G., & Pecaut, M. J. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22828 · Cited by 44
Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
Ning, S., Jorfi, M., Patel, S. R., Kim, D. Y., & Tanzi, R. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.854992 · Cited by 43
Self-citationMondal, P., Bai, P., Gomm, A., Bakiasi, G., Lin, C., Wang, Y., Choi, S. H., Tanzi, R. E., Wang, C., & Zhang, C. M. (2023) · Advanced Science · doi:10.1002/advs.202304545 · Cited by 43
Self-citationYarbro, J. M., Han, X., Dasgupta, A., Yang, K., Liu, D., Shrestha, H. K., Zaman, M., Wang, Z., Yu, K., Lee, D. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56853-3 · Cited by 41
Kucińska, M., Murias, M., & Nowak-Sliwinska, P. M. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.09.002 · Cited by 42
Yan, Y., Song, L., Madinya, J. J., Ma, T., & Li, Y. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0400 · Cited by 41
Marzano, M., Bejoy, J., Cheerathodi, M. R., Sun, L. J., York, S. B., Zhao, J., Kanekiyo, T., Bu, G., Meckes, D. G., & Li, Y. (2019) · Cells · doi:10.3390/cells8090993 · Cited by 41
A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise
Pearse, Y., & Iacovino, M. (2020) · Medical Research Archives · doi:10.18103/mra.v8i2.2045 · Cited by 39
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Si, Z., & Wang, X. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000324 · Cited by 42
USP10 deubiquitinates Tau, mediating its aggregation
Wei, Z. C., Zeng, K., Hu, J., Li, X., Huang, F., Zhang, B., Wang, J., Liu, R., Li, H., & Wang, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05170-4 · Cited by 44
Cell-Based Screening: Extracting Meaning from Complex Data
Finkbeiner, S. M., Frumkin, M. A., & Kassner, P. D. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.023 · Cited by 40
Watmuff, B., Berkovitch, S. S., Huang, J., Iaconelli, J., Toffel, S., & Karmacharya, R. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.003 · Cited by 40
Human astrocytes are distinct contributors to the complexity of synaptic function
Krencik, R., van Asperen, J. V., & Ullian, E. M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.012 · Cited by 43
Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease
Inak, G., Lorenz, C., Lisowski, P., Zink, A., Mlody, B., & Prigione, A. (2017) · Stem Cells · doi:10.1002/stem.2637 · Cited by 41
Materials for Neural Differentiation, Trans‐Differentiation, and Modeling of Neurological Disease
Gong, L., Cao, L., Shen, Z., Shao, L., Gao, S., Zhang, C., Lü, J., & Li, W. (2018) · Advanced Materials · doi:10.1002/adma.201705684 · Cited by 40
Self-citationTranslational potential of human brain organoids
Sun, A. X., Ng, H., & Tan, E. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.505 · Cited by 45
Karch, S., Broichhagen, J., Schneider, J., Böning, D., Hartmann, S., Schmid, B., Tripal, P., Palmisano, R., Alzheimer, C., Johnsson, K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00387 · Cited by 39
Marotta, N., Kim, S., & Krainc, D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1703671 · Cited by 40
Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
Chuang, Y. C., Van, I., Zhao, Y., & Xu, Y. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102014 · Cited by 41
Alternative platelet activation pathways and their role in neurodegenerative diseases
Ferrer-Raventós, P., & Beyer, K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105512 · Cited by 39
Yue, F., Feng, S., Lu, C., Zhang, T., Tao, G., Liu, J., Yue, C., & Jing, N. (2021) · iScience · doi:10.1016/j.isci.2021.103207 · Cited by 41
Rao, A. T., Chen, N., Kim, M. J., Blumenfeld, J. R., Yip, O., Liang, Z., Shostak, D. M., Hao, Y., Nelson, M. R., Koutsodendris, N., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.005 · Cited by 48
Weissmiller, A. M., Natera-Naranjo, O., Reyna, S. M., Pearn, M. L., Zhao, X., Nguyen, P. A. H., Cheng, S., Goldstein, L. S. B., Tanzi, R. E., Wagner, S. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118379 · Cited by 37
Self-citationHou, P.-S., Chuang, C.-Y., Yeh, C.-H., Chiang, W. F., Liu, H.-J., Lin, T., & Kuo, H. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.11.006 · Cited by 38
Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons
Miguel, L., Rovelet‐Lecrux, A., Feyeux, M., Frébourg, T., Nassoy, P., Campion, D., & Lecourtois, M. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101541 · Cited by 37
The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration
Engstrom, A., Walker, A. C., Moudgal, R. A., Myrick, D. A., Kyle, S. M., Bai, Y., Rowley, M. J., & Katz, D. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013552117 · Cited by 39
Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia
Albert, K., Niskanen, J., Kälvälä, S., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094334 · Cited by 40
Neuromuscular Development and Disease: Learning From in vitro and in vivo Models
Fralish, Z., Lotz, E. M., Chavez, T., Khodabukus, A., & Bursac, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764732 · Cited by 40
Harnessing cerebral organoids for Alzheimer's disease research
Bubnys, A., & Tsai, L. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.10.003 · Cited by 41
Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34005-1 · Cited by 43
Increased maturation of iPSC-derived neurons in a hydrogel-based 3D culture
de Leeuw, S. M., Davaz, S., Wanner, D., Milleret, V., Ehrbar, M., Gietl, A. F., & Tackenberg, C. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109254 · Cited by 38
Carbone, M. G., Pagni, G., Tagliarini, C., Imbimbo, B. P., & Pomara, N. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101420 · Cited by 39
D’Antoni, C., Mautone, L., Sanchini, C., Tondo, L., Grassmann, G., Cidonio, G., Bezzi, P., Cordella, F., & Angelantonio, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310762 · Cited by 41
Hunsberger, J. G., Efthymiou, A. G., Malik, N., Behl, M., Mead, I., Zeng, X., Simeonov, A. M., & Rao, M. S. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0531 · Cited by 38
Onoe, H., Kato‐Negishi, M., Itou, A., & Takeuchi, S. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500903 · Cited by 38
Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
Fang, Y., Gao, T., Zhang, B., & Pu, J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00077 · Cited by 39
Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling
Beghini, D. G., Kasai-Brunswick, T. H., & Henriques‐Pons, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042392 · Cited by 37
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Rowland, H. A., Hooper, N. M., & Kellett, K. A. B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2663-z · Cited by 38
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Wang, X., Williams, D., Müller, I. I., Lemieux, M., Dukart, R., Maia, I. B. L., Wang, H., Woerman, A. L., & Schmitt‐Ulms, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-52543-5 · Cited by 37
Abrahamson, E. E., Zheng, W., Muralidaran, V., Ikonomović, M. D., Bloom, D. C., Nimgaonkar, V. L., & D’Aiuto, L. (2020) · Journal of Virology · doi:10.1128/jvi.02219-20 · Cited by 39
Toward three-dimensional in vitro models to study neurovascular unit functions in health and disease
Robert, J., Caffrey, T. M., & Button, E. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310671 · Cited by 37
Tools for studying human microglia: In vitro and in vivo strategies
Warden, A. S., Han, C. Z., Hansen, E. A., Trescott, S., Nguyen, C. T., Kim, R. Y., Schafer, D. M., Johnson, A., Wright, M., Ramírez, G., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.008 · Cited by 38
Advances in current in vitro models on neurodegenerative diseases
Pereira, I., Lopez-Martinez, M. J., & Samitier, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1260397 · Cited by 35
Neziri, S., Köseoğlu, A. E., Köseoğlu, G. D., Özgültekin, B., & Özgentürk, N. Ö. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12487 · Cited by 40
Weller, R. O., Hawkes, C. A., Carare, R. O., & Hardy, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1416-1 · Cited by 36
Human Neural Tissue Construct Fabrication Based on Scaffold‐Free Tissue Engineering
Takahashi, H., Itoga, K., Shimizu, T., Yamato, M., & Okano, T. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600197 · Cited by 37
Biological basis for amyloidogenesis in Alzheimer’S disease
Андреева, Т. В., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 38
Metadata
- Authors
- Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., & Kim, D. Y.
- Affiliations
- Harvard University (US)
- University of Bonn (DE)
- Boston Children's Hospital (US)
- Whitehead Institute for Biomedical Research (US)
- University of California San Diego (US)
- Corresponding author
- Tanzi, Rudolph E.
- Kim, Doo Yeon
- ORCID
- Venue
- Nature
- Published
- 2014-10-12
- Volume
- 515
- Issue
- 7526
- Pages
- 274-278
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4366007
- OpenAlex
- W2126231259
- Cited by
- 1,195
- References
- 30
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 95 · 2023: 88 · 2022: 112 · 2021: 111 · 2020: 141 · 2019: 109 · 2018: 109 · 2017: 87 · 2016: 97 · 2015: 87 · 2014: 14
- FWCI
- 63.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Massachusetts General Hospital
- Cure Alzheimer's Fund
- University of Edinburgh
- National Institute on Aging (5P01 AG15379, P01AG015379, R21AG031483, RF1AG048080, P50AG005134, R01AG014713, P01AG004953, P30AG062421)
- National Institute of Mental Health (R37MH060009)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
- National Institute of Neurological Disorders and Stroke (P30NS045776, R01NS045860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, familial Alzheimer's disease, amyloid plaques, tauopathy, neurofibrillary tangles, amyloid hypothesis, presenilin 1 mutations, human neural stem cells, 3D cell culture, human neurons, beta-secretase inhibition, gamma-secretase inhibition, tau phosphorylation, drug screening model
- MeSH terms
- Alzheimer Disease, Cell Differentiation, Drug Evaluation, Preclinical, Extracellular Space, Humans, Microtubule-Associated Proteins, Models, Biological, Phosphorylation, Reproducibility of Results, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Culture Techniques, Glycogen Synthase Kinase 3, Presenilin-1, Neural Stem Cells, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
